Dynogen Pharmaceuticals, Inc. Obtains $3,999,900 New Round

  • Feed Type
  • Date
  • Company Name
    Dynogen Pharmaceuticals, Inc.
  • Mailing Address
    52 Second Avenue Waltham, MA 02451
  • Company Description
    Dynogen Pharmaceuticals, Inc., is a neuroscience-based drug discovery and development company targeting first-in-class and best-in-class therapies for genitourinary and gastrointestinal disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor

Trending on Xconomy